Sally Church· @MaverickNY · X·· 18 hours agoScore45
Body
Red and green flag analysis of Tango Therapeutics' PRMT5 inhibitor in combination with $RVMD daraxonrasib in pancreatic cancer at #ESMO26
Elicio's vaccine didn't pan out after encouraging Ph1 data – will this go the same way?
https://tinyurl.com/2hbaj5zy
306 views · 5 likes · 0 reposts · 0 replies
Conference abstracts
LBA82matched by Proffered paper 1: Gastrointestinal tumour, upper digestive
Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Additional subgroup analyses from the ph3 RASolute 302 study
https://esmocongress.esmo.orgSource: Sally Church · x.com